Record Order Flow and Backlog Growth
Funded backlog grew to $1.1 billion and year-to-date total awards reached a record $4.6 billion; funded backlog provides strong visibility into Q4 and FY2027 demand.
Strong Q3 Organic Revenue Growth
Reported Q3 revenue of $408 million; legacy AV organic growth of 38% year-over-year in the quarter (company noted revenue was +143% YoY as reported and +6% on a pro forma basis).
Revised FY'26 Guidance Reflects Continued Growth
Updated full-year revenue guidance raised to $1.85–$1.95 billion (midpoint ~12% pro forma growth over FY'25); adjusted EBITDA guidance set at $265–$285 million and non-GAAP EPS of $2.75–$3.10.
Major Contract Awards and Wins
Awarded a 5-year sole-source IDIQ worth $874 million for UAS and counter-UAS (FMS); received a $168 million U.S. Army task order for Switchblade 300 Block 20 and Switchblade 600 Block 2; additional $23 million Titan SV award from USMC; $96 million FE-1 award progressing toward flight testing.
Margin and Profitability Momentum (Non-GAAP)
Adjusted EBITDA for Q3 was $44 million (11% margin), up from $22 million in prior-year Q3; adjusted Q3 diluted EPS was $0.64 versus $0.30 prior-year.
Manufacturing Scale and Capacity Expansion
Progressing a 140,000 sq ft Salt Lake City facility expected to be operational in ~1 year with potential to produce >$2 billion of Switchblade or other AV products annually; Titan production to increase >4x this year and >10x by FY2030.
Space & Directed Energy Commercialization Progress
Delivered two JLTV-mounted LOCUST laser systems to U.S. Army; LOCUST and other SCD&E technologies (laser comms, laser gunsight) being transitioned to commercial product models to enable scalable production and improved margins; Golden Dome opportunity estimated at ~$0.5 billion over 3 years.
Operational Discipline and Synergies
Year-to-date realization of expected Year 1 synergies from the BlueHalo acquisition; adjusted SG&A of $61 million (15% of revenue) improved versus prior-year percentage and expected to fall to 13–14% by year-end.